Glutamatergic dysfunction in major depressive disorder: From receptor and glial abnormalities to circuit pathology and mechanism-based therapeutic strategies
Publication date: November 2026 Source: Brain Research Bulletin, Volume 246 Author(s): Xingyu Chen, Qing Chen, Yan Long, Shixiong Huang, Chang Li, Dan Zhu, Xinyu Ben
Glutamatergic dysfunction in major depressive disorder: From receptor and glial abnormalities to circuit pathology and mechanism-based therapeutic strategies. // American Journal of Pharmaceutical Education. – URL: https://www.sciencedirect.com/science/article/pii/S0361923026004934?dgcid=rss_sd_all
Glutamatergic dysfunction in major depressive disorder: From receptor and glial abnormalities to circuit pathology and mechanism-based therapeutic strategies. American Journal of Pharmaceutical Education. https://www.sciencedirect.com/science/article/pii/S0361923026004934?dgcid=rss_sd_all
“Glutamatergic dysfunction in major depressive disorder: From receptor and glial abnormalities to circuit pathology and mechanism-based therapeutic strategies.” American Journal of Pharmaceutical Education.
@article{article13698,
title = {Glutamatergic dysfunction in major depressive disorder: From receptor and glial abnormalities to circuit pathology and mechanism-based therapeutic strategies},
journal = {American Journal of Pharmaceutical Education},
url = {https://www.sciencedirect.com/science/article/pii/S0361923026004934?dgcid=rss_sd_all}
}